Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 26, 2007
app pub date -
Apr 29, 2004
filing date -
May 1, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Compounds of formula (I) and their use in therapy, particularly for the treatment of a disorder mediated by CB.sub.1 receptors, such as obesity, wherein: R.sup.1 is aryl or heteroaryl; R.sup.2 is alkyl, aryl or heteroaryl; R.sup.3 is alkyl, aryl, heteroaryl, NR.sup.9R.sup.10, OR.sup.15, or NR.sup.16C(O)R.sup.17; Y is C.dbd.O, C.dbd.S, SO.sub.2, or (CR.sup.7R.sup.8); m=1 or 2; n=1 or 2; and p=1, 2, 3 or 4, R.sup.7 to R.sup.17 being as defined in the specification; wherein if --Y--R.sup.3 is --C(O)NH(alkyl) then: R.sup.1 and/or R.sup.2 is selected from heteroaryl; and/or m and/or n is 2; and/or R.sup.11 and/or R.sup.12 is lower alkyl, or a pharmaceutically acceptable salt or prodrug thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully